Author

Jamie P. Nourse

Johannes Gutenberg University Mainz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Sven DanckwardtiD· 2 shared Danielle Arnold-Schild· 1 shared Essak Khan· 1 shared Hans Christian ProbstiD· 1 shared Hugo Ten CateiD· 1 shared Johanna Satrapa· 1 shared Karl Johannes LackneriD· 1 shared Lina K. Schott· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Sven DanckwardtORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Non-invasive imaging of gene expression and protein secretion dynamics in living mice: identification of ectopic prothrombin expression as driver of thrombosis in cancer

Jamie P. Nourse, Sergey Tokalov, Shazad Khokhar, Essak Khan, Lina K. Schott, Lisa Hinz, Ludwig Eder, Danielle Arnold-Schild, Johanna Satrapa, Karl Johannes Lackner, Hugo Ten Cate, Hans Christian Probst, Sven Danckwardt

This paper introduces a genetic tagging strategy to non-invasively image secretory protein dynamics in living mice, revealing ectopic prothrombin expression in tumors that contributes to thrombosis.

bioRxiv · Jul 8, 2021 · PreprintGenetics

A novel rationale for targeting FXI: Insights from the hemostatic miRNA targetome for emerging anticoagulant strategies

Jamie P. Nourse, Sven Danckwardt

The paper introduces a novel rationale for targeting factor XI using miRNA mimics to develop anticoagulants that avoid disrupting hemostasis.

Pharmacology & Therapeutics · Sep 6, 2020Peer-reviewedMolecular Biology